Standardized Medication Profile (SMP) FHIR IG, published by HL7 International / Pharmacy. This guide is not an authorized publication; it is the continuous build for version 1.0.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/smp-ig/ and changes regularly. See the Directory of published versions
| Page standards status: Informative |
status: Preliminary
code: Duplicate Therapy Alert
severity: High
patient: John Doe (official) Male, DoB: 1960-01-01 ( http://hospital.example.com/mrn#12345)
identified: 2025-07-02 08:00:00+0000
author: Practitioner Pharmy Anyperson (official)
implicated:
detail: Taking these medications contribute a risk of anticholinergic side effects that increase risk of cognitive impairment, dementia and falls.
| Action | Date | Author |
| Discontinue noted medications to prevent cognitive worsening, due to duplicative impact with other anticholinergics. | 2025-07-02 08:00:00+0000 | Practitioner Pharmy Anyperson (official) |